Literature DB >> 3985939

Fragmentation and reduction of bovine secretory component. Preparation of a biologically active fragment and some evidence for a multiple-domain structure.

D Beale, J G Hopley.   

Abstract

A tryptic fragment (A) of Mr 25000 was prepared from bovine secretory component. The fragment binds polymeric immunoglobulin, although 9 times less effectively than secretory component on a molar basis. The fragment has four buried half-cystine residues and two exposed half-cystine residues. It gives rise to two fragments of Mr 11000-13000 on prolonged digestion with trypsin, and these do not bind polymeric immunoglobulin. It is proposed that fragment A consists of two immunoglobulin-like domains. Bovine secretory component was found to have 9-11 buried half-cystine residues and four exposed half-cystine residues. Reduction and alkylation of the exposed residues decreases the binding of polymeric immunoglobulin by 3-fold. Initial tryptic cleavage of bovine secretory component gives a fragment (Q) disulphide-bridged to a further fragment (T). Fragment Q is similar in size to a three-domain immunoglobulin fragment, and fragment T is similar in size to a two-domain immunoglobulin fragment. The two-domain fragment A is derived from fragment Q by further tryptic cleavage. The results are compatible with the proposal by Mostov, Friedlander & Blobel [(1984) Nature (London) 308, 37-43] that secretory component consists of multiple immunoglobulin-like domains. The results also indicate that optimal binding of polymeric immunoglobulin involves several domains stabilized by an exposed disulphide bridge.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3985939      PMCID: PMC1144763          DOI: 10.1042/bj2260661

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

Review 1.  STRUCTURE AND BIOLOGICAL ACTIVITY OF IMMUNOGLOBULINS.

Authors:  S COHEN; R B PORTER
Journal:  Adv Immunol       Date:  1964       Impact factor: 3.543

2.  Isolation of a new glycoprotein-a and a gamma-G-globulin from individual cow milks.

Authors:  M L Groves; W G Gordon
Journal:  Biochemistry       Date:  1967-08       Impact factor: 3.162

Review 3.  Structure and biological properties of immunoglobulins.

Authors:  S Cohen; C Milstein
Journal:  Adv Immunol       Date:  1967       Impact factor: 3.543

Review 4.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

Review 5.  Structure and function of gamma M macroglobulins.

Authors:  H Metzger
Journal:  Adv Immunol       Date:  1970       Impact factor: 3.543

6.  Characterization of a human macroglobulin. 3. The products of tryptic digestion.

Authors:  F Miller; H Metzger
Journal:  J Biol Chem       Date:  1966-04-25       Impact factor: 5.157

7.  Studies on a human 19-S immunoglobulin M. The arrangement of inter-chain disulphide bridges and carbohydrate sites.

Authors:  D Beale; N Buttress
Journal:  Biochim Biophys Acta       Date:  1969-05

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Physicochemical and immunochemical studies on bovine IgA and glycoprotein-a.

Authors:  J E Butler
Journal:  Biochim Biophys Acta       Date:  1971-12-28

10.  Studies on the reduction of a human 19S immunoglobulin M.

Authors:  D Beale; A Feinstein
Journal:  Biochem J       Date:  1969-04       Impact factor: 3.857

View more
  2 in total

1.  A bovine epithelial membrane protein that binds polymeric immunoglobulin and has a structure related to that of bovine secretory component.

Authors:  D Beale; J Hopley
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

2.  Differences in fragmentation between bound and unbound bovine secretory component suggest a model for its interaction with polymeric immunoglobulin.

Authors:  D Beale
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.